This topic contains a solution. Click here to go to the answer

Author Question: A patient has suffered a burn to the skin. Based on the functions of the skin, to which of the ... (Read 83 times)

CORALGRILL2014

  • Hero Member
  • *****
  • Posts: 525
A patient has suffered a burn to the skin. Based on the functions of the skin, to which of the following conditions is the patient most susceptible?
 
  a. Infection
  b. Fluid overload
  c. Heart problems
  d. Endocrine disorders

Question 2

Which of the following lists identifies the regions of the spinal column from superior to inferior?
 
  a. Cervical, lumbar, thoracic, sacral, and coccyx
  b. Coccyx, lumbar, thoracic, cervical, and sacral
  c. Thoracic, lumbar, cervical, coccyx, and sacral
  d. Cervical, thoracic, lumbar, sacral, and coccyx



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

wshriver

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

Answer: a

Answer to Question 2

Answer: d




CORALGRILL2014

  • Member
  • Posts: 525
Reply 2 on: Jul 2, 2018
Great answer, keep it coming :)


covalentbond

  • Member
  • Posts: 336
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

Symptoms of kidney problems include a loss of appetite, back pain (which may be sudden and intense), chills, abdominal pain, fluid retention, nausea, the urge to urinate, vomiting, and fever.

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library